Last updated on August 2020

Durvalumab Long-Term Safety and Efficacy Study


Brief description of study

The aims of the study are to monitor the long-term safety of durvalumab, to provide continued treatment or retreatment with durvalumab to eligible patients, and to collect overall survival (OS) information.

Detailed Study Description

This is a multicenter, open-label, global study that will enroll patients who are currently receiving durvalumab monotherapy, or have previously received durvalumab as monotherapy or in combination with any other approved or investigational anticancer agents, in an eligible AstraZeneca/MedImmune-sponsored clinical study.

Clinical Study Identifier: NCT04078152

Find a site near you

Start Over

Research Site

Suita-shi, Japan
4.09miles
  Connect »

Research Site

Osaka-shi, Japan
7.22miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.